Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The (Q31360797)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The |
scientific article |
Statements
1 reference
Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The (English)
1 reference
Takenaka T
1 reference
Mikuni C
1 reference
Miura A
1 reference
Sasaki T
1 reference
Suzuki H
1 reference
Hotta T
1 reference
Hirano M
1 reference
Fukuhara S
1 reference
Sugiyama H
1 reference
Nasu K
1 reference
Dohi H
1 reference
Kozuru M
1 reference
Tomonaga M
1 reference
Tajima K
1 reference
Niimi M
1 reference
Fukuda H
1 reference
Mukai K
1 reference
Shimoyama M
1 reference
1 March 2000
1 reference
1 reference
146-152
1 reference
Identifiers
1 reference
1 reference